Baseline Nexus (MNT+LPP+MTHFR+Telomere)

SpectraCell's micronutrient test evaluates intracellular nutrient sufficiency by stimulating peripheral blood lymphocytes in culture and measuring their functional metabolic performance. This approach assesses the bioavailable fraction of vitamins, minerals, antioxidants, and amino acids required for optimal cellular metabolism, rather than static serum or plasma concentrations. The panel typically reports on B vitamins, minerals (magnesium, calcium, zinc, copper, selenium), vitamins A, C, D, E, K2, coenzyme Q10, lipoic acid, glutathione, serine, oleic acid, and carnitine.

Functional micronutrient assessment informs repletion strategies when serum levels do not correlate with clinical symptoms or when practitioners are investigating fatigue, impaired immunity, cardiovascular risk, or cognitive function that may reflect hidden insufficiency. The intracellular functional approach aims to identify marginal deficiencies missed by standard plasma assays.

Lipoprotein particles are the cholesterol- and triglyceride-carrying vehicles in the circulation, and particle number and size provide additional cardiovascular risk stratification beyond standard lipid mass measurements. Small, dense LDL particles are more atherogenic per unit cholesterol than large, buoyant LDL, and LDL-P has been shown to correlate more strongly with cardiovascular events than LDL cholesterol alone. HDL particle number reflects the functional capacity of reverse cholesterol transport.

Particle profiling refines risk assessment in patients with discordant lipid and apolipoprotein results, metabolic syndrome, diabetes, or familial dyslipidaemia, guiding lipid-lowering therapy intensity and monitoring therapeutic response. Small dense LDL and elevated LDL-P identify residual risk even when LDL cholesterol is at target.

MTHFR is the enzyme that reduces 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the methyl donor for homocysteine remethylation to methionine. The C677T variant reduces enzyme thermostability and activity (homozygous ~70% reduction), particularly when folate status is suboptimal. The A1298C variant has a smaller effect on activity. The double heterozygous 677CT/1298AC genotype is also reported.

MTHFR genotyping is ordered when investigating unexplained hyperhomocysteinaemia, recurrent thrombosis, recurrent pregnancy loss, or as part of a personalised nutrition and methylation assessment. The clinical significance of isolated MTHFR variants without hyperhomocysteinaemia is contested; the common polymorphism is not by itself an indication for anticoagulation, and the relationship to disease is context-dependent.

Telomeres are repetitive TTAGGG hexanucleotide sequences at chromosome ends that protect coding DNA from degradation. With each cell division telomeres shorten unless telomerase is active, and critically short telomeres trigger senescence or apoptosis. Telomere length in peripheral blood leucocytes serves as a marker of cumulative oxidative stress, inflammation, and biological ageing. Shorter age-adjusted telomere length has been associated epidemiologically with cardiovascular disease, type 2 diabetes, and mortality, though the causal relationship is debated.

Telomere length measurement is used in longevity and preventive medicine to stratify biological age and to motivate or monitor lifestyle interventions. It is an exploratory rather than diagnostic marker; no clinical guidelines recommend routine telomere testing for disease management, and there is considerable inter-individual variability independent of disease.

The total antioxidant function score integrates the sufficiency of multiple antioxidant nutrients and enzyme systems (glutathione, vitamins C and E, alpha-lipoic acid, coenzyme Q10, selenium) measured functionally in lymphocytes. It reflects the cell's capacity to buffer oxidative stress rather than a single molecule's serum concentration.

A reduced antioxidant function score may signal heightened oxidative stress or marginal nutrient status in conditions such as chronic inflammation, cardiovascular disease, diabetes, or neurodegenerative disorders. It complements individual micronutrient results by providing a systems-level view of redox balance.

The Immunidex score integrates functional measures of lymphocyte proliferation and metabolic response under nutritional challenge. It is intended to reflect the adequacy of nutrient support for immune-cell function, including B vitamins, antioxidants, and minerals required for lymphocyte activation and cytokine production.

A low Immunidex may suggest marginal nutrient sufficiency affecting immune resilience, relevant in patients with recurrent infections, chronic viral reactivation, or impaired wound healing. The score is exploratory and complements traditional immune markers.

SpectrOx quantifies the oxidative damage to lymphocytes by measuring intracellular reactive-species generation and its impact on cellular DNA and lipid membranes. It is a dynamic functional assay intended to reflect the net balance between oxidative challenge and antioxidant defences.

Elevated oxidative stress is implicated in accelerated ageing, cardiovascular disease, neurodegenerative disorders, and metabolic syndrome. The SpectrOx marker informs antioxidant repletion strategies and lifestyle modification, though it is not a substitute for direct markers of tissue damage such as F2-isoprostanes or oxidised LDL.